RO63065A - Procede d'obtention d'un inhibiteur de glycosidehydrolase - Google Patents

Procede d'obtention d'un inhibiteur de glycosidehydrolase

Info

Publication number
RO63065A
RO63065A RO7181890A RO8189071A RO63065A RO 63065 A RO63065 A RO 63065A RO 7181890 A RO7181890 A RO 7181890A RO 8189071 A RO8189071 A RO 8189071A RO 63065 A RO63065 A RO 63065A
Authority
RO
Romania
Prior art keywords
glycosidehydrolase
inhibitor
obtaining
glycosidehydrolase inhibitor
Prior art date
Application number
RO7181890A
Other languages
English (en)
Romanian (ro)
Inventor
Werner Frommer
Walter Puls
Dietmar Schaefer
Delf Schmidt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of RO63065A publication Critical patent/RO63065A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
RO7181890A 1970-12-28 1971-12-24 Procede d'obtention d'un inhibiteur de glycosidehydrolase RO63065A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (1)

Publication Number Publication Date
RO63065A true RO63065A (fr) 1979-02-15

Family

ID=5792372

Family Applications (3)

Application Number Title Priority Date Filing Date
RO9182*[A RO61400A (fr) 1970-12-28 1971-12-24
RO7181890A RO63065A (fr) 1970-12-28 1971-12-24 Procede d'obtention d'un inhibiteur de glycosidehydrolase
RO7100081898A RO63064A (fr) 1970-12-28 1971-12-24 Procede d'obtenir un inhibiteur pour glycosidhydrolases

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RO9182*[A RO61400A (fr) 1970-12-28 1971-12-24

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO7100081898A RO63064A (fr) 1970-12-28 1971-12-24 Procede d'obtenir un inhibiteur pour glycosidhydrolases

Country Status (28)

Country Link
US (1) US3876766A (fr)
JP (3) JPS5734996B1 (fr)
KR (1) KR780000248B1 (fr)
AR (1) AR193370A1 (fr)
AT (1) AT330122B (fr)
AU (1) AU461521B2 (fr)
BE (1) BE777387A (fr)
BG (3) BG25654A3 (fr)
CA (1) CA979833A (fr)
CH (1) CH594051A5 (fr)
CS (1) CS167961B2 (fr)
DD (1) DD99395A5 (fr)
DE (1) DE2064092C2 (fr)
DK (1) DK139533C (fr)
ES (1) ES398358A1 (fr)
FI (1) FI49774C (fr)
FR (1) FR2120073B1 (fr)
GB (1) GB1374751A (fr)
IE (1) IE35920B1 (fr)
IL (1) IL38441A (fr)
LU (1) LU64319A1 (fr)
NL (1) NL175199C (fr)
NO (1) NO135873C (fr)
PL (1) PL82900B1 (fr)
RO (3) RO61400A (fr)
SE (1) SE398357B (fr)
SU (1) SU454750A3 (fr)
ZA (1) ZA718677B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (fr) * 1978-02-14 1982-04-06 Yasuji Suhara Derives amines d'un sucre
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
EP0257418B1 (fr) * 1986-08-13 1993-05-19 Hoechst Aktiengesellschaft Oxirane-pseudo-oligosaccharides, procédé pour leur synthèse, leur utilisation et préparations pharmaceutiques
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (fr) * 1996-03-22 1999-04-14 Bayer Ag Procédé de préparation et utilisation d'acarviosyl-transferase dans la conversion d'homologues d'acarbose et dans la préparation d'homologues d'acarbose
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
JP3992497B2 (ja) 1999-10-28 2007-10-17 チョン・クン・ダン・ファーマシューティカル・コーポレーション 高純度アカルボース製造方法
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
KR20140109922A (ko) 2011-12-08 2014-09-16 바이엘 인텔렉쳐 프로퍼티 게엠베하 연관된 방선균의 유전적 형질전환을 위한 플라스미드인 액티노플라네스 sp. SE50/110으로부터 유래한 신규한 방선균류 통합 및 접합 인자
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
KR20220081991A (ko) 2019-10-16 2022-06-16 바이엘 악티엔게젤샤프트 아카르보스의 개선된 형성을 위한 방법
CA3172525A1 (fr) 2020-03-23 2021-09-30 Tanya Jeradechachai Test rapide de purete de grains de ble a haute teneur en amylose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
FI49774B (fr) 1975-06-30
JPS57150395A (en) 1982-09-17
LU64319A1 (fr) 1972-06-13
ATA1111571A (de) 1975-09-15
SE398357B (sv) 1977-12-19
FI49774C (fi) 1975-10-10
AR193370A1 (es) 1973-04-23
ZA718677B (en) 1972-09-27
CS167961B2 (fr) 1976-05-28
US3876766A (en) 1975-04-08
ES398358A1 (es) 1974-09-01
NL7117893A (fr) 1972-06-30
JPS6216638B2 (fr) 1987-04-14
DE2064092A1 (de) 1972-07-20
AU3721471A (en) 1973-09-27
CH594051A5 (fr) 1977-12-30
BG26003A4 (bg) 1979-01-12
IL38441A (en) 1974-10-22
KR780000248B1 (en) 1978-07-06
DK139533C (da) 1979-08-20
FR2120073B1 (fr) 1975-12-26
BG26002A4 (bg) 1979-01-12
NO135873B (fr) 1977-03-07
FR2120073A1 (fr) 1972-08-11
GB1374751A (en) 1974-11-20
NL175199B (nl) 1984-05-01
JPS5734996B1 (fr) 1982-07-26
RO63064A (fr) 1978-06-15
DK139533B (da) 1979-03-05
RO61400A (fr) 1977-01-15
BE777387A (fr) 1972-06-28
DD99395A5 (fr) 1973-08-05
IE35920B1 (en) 1976-06-23
IE35920L (en) 1972-06-28
SU454750A3 (ru) 1974-12-25
DE2064092C2 (de) 1983-06-01
AU461521B2 (en) 1975-05-29
NL175199C (nl) 1984-10-01
JPS57150396A (en) 1982-09-17
CA979833A (en) 1975-12-16
BG25654A3 (bg) 1978-11-10
JPS6234396B2 (fr) 1987-07-27
AT330122B (de) 1976-06-10
IL38441A0 (en) 1972-02-29
NO135873C (fr) 1977-06-15
PL82900B1 (fr) 1975-10-31

Similar Documents

Publication Publication Date Title
RO63065A (fr) Procede d'obtention d'un inhibiteur de glycosidehydrolase
IT1060656B (it) Metodo di funzionamento di un dispositivo per la formazione di immagini
BE775859A (fr) Procede d'inhibition de la corrosion a l'aide d'amino-diphosphonates
BE795996A (fr) Procede de preparation d'un inhibiteur de saccharase
BE796835A (fr) Procede d'extraction de metaux
BE747196A (fr) Procede de production d'un metal pre-enduit
BE804236A (fr) Procede d'extraction de polylactames
BG25985A3 (bg) Метод за получаване на 13 бета-етил-17 d-етинил-гон- -4-еп-3-он-17 бета-ол
BE770317A (fr) Procede d'obtention de substances polyflavaniques a activite coronarodilatatrice
CH551760A (fr) Procede d'obtention d'un principe modificateur du gout.
RO64465A (fr) Procede d'obtention de la n-diethyleaminoethyle-2-methoxy-4-amino-5-chlorebenzamide
BE770523A (fr) Procede pour l'obtention d'hellebrine
BE777069A (fr) Procede d'obtention d'hydrogenochlorosilanes
SU426992A1 (fr)
SU469764A1 (ru) Сталь
RO63472A (fr) Procede pour obtenir un inhibiteur d'amylase
RO77618A (fr) Procede pour l'obtention des inhibiteur de sucrose
SU425946A1 (fr)
SU453236A1 (fr)
BE803679A (fr) Procede de fabrication d'un compost
BG22819A3 (bg) Метод за получаване на 3--амино-пиразолони-(5)
BE807081A (fr) Procede d'extraction
BE806254A (fr) Procede d'extraction
SU462878A1 (ru) Сталь
BE769619A (fr) Procede de preparation d'un pyroglutamylpeptide